MedPlus Health Services Limited IPO

MedPlus Health Services Limited IPO is listed on BSE and NSE, priced at ₹780–₹796 per share. The stock debuted at ₹1040, delivering a listing gain of 30.7%. The IPO had a lot size of ₹18 shares and a minimum investment of ₹14,328.

MedPlus Health Services Limited IPO

Mainboard Listed
₹14,328 (18 Shares)
Minimum Investment
Check Allotment
IPO Dates
Dec 13, 2021 – Dec 15, 2021
Price band
₹780-796 per equity share
Minimum Investment
₹14,328
Issue size
₹1,397.81 Cr
Lot size
18
Allotment Date
Dec 20, 2021
Listing
Dec 23, 2021
Listing At
BSE, NSE

IPO timeline

  1. Dec 13, 2021

    Open Date

    Completed

  2. Dec 15, 2021

    Close Date

    Completed

  3. Dec 20, 2021

    Allotment Date

    Completed

  4. Dec 23, 2021

    Listing Date

    Completed

Price Summary

Last closing
891.55 (12%)
52 week high
1,045.30
52 week low
732.00
Last update

MedPlus Health Services Limited IPO Essentials

MedPlus Health Services Limited IPO Details

MedPlus Health Services Limited IPO is priced at ₹780-796 per share with a total issue size of ₹1,397.81 Cr. The IPO has a lot size of 18 shares and is listed on BSE and NSE.

Issue price
₹780-796 per equity share
Lot size
18 shares
Face value
₹2 Per Equity Share 
Issue size
₹1,397.81 Cr
Listing at
BSE, NSE
List price
1040.00(NSE)
Listing date
Registrar
KFin Technologies Private Limited
Lead manager
Axis Capital Limited, Credit Suisse Securities (India) Private Limited, Edelweiss Financial Services Limited, and Nomura Financial Advisory and Securities (India) Private Limited

MedPlus Health Services Limited IPO Details

  • Retail Portion 35% (Number of Retail Applications : 3,40,300 Approx)

MedPlus Health Services Limited IPO Documents

MedPlus Health Services Limited IPO Analytics

MedPlus Health Services Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.

MedPlus Health Services Limited IPO Subscription Status

MedPlus Health Services Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.

The IPO subscription status indicates investor demand across categories.

As on QIB
NII
Retail Employee Total
Shares Offered / Reserved 35,00,741
26,25,556
61,26,297 69,637 123,22,231
Day 1 13-12-21 05:00 PM
0.06 x
0.16x
1.29 x 0.76 x 0.70 x
Day 2 14-12-21 05:00 PM
0.08 x
0.51x
2.64 x 1.74 x 1.45 x
Day 3 15-12-21 05:00 PM
111.89 x
85.34x
5.23 x 3.05 x 52.59 x
Total No. of Applications
category wise applications
1636346 (Approx) 4.81

MedPlus Health Services Limited Valuations

Earnings

EPS (Post IPO)
₹5.61/-
P/E Ratio
141.91

Returns

RoNW
8.74%

Data sourced from DRHP / RHP • For educational purposes only

MedPlus Health Services Limited Financials( In Crs.)

31-Mar-21 31-Mar-20 31-Mar-19
Assets 1,565.65 1,348.69 958.71
Revenue 3,090.81 2,887.88 2,284.94
Profit After Tax 63.11 1.79 11.92

MedPlus Health Services Limited Company & Offer Insights

About MedPlus Health Services Limited

They are the second-largest pharmacy retailer in India, in terms of (i) revenue from operations for the financial year 2021, and (ii) the number of stores as of March 31, 2021, according to the Technopak Report. They offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.

Their Company was founded in 2006 by Gangadi Madhukar Reddy, their Managing Director and Chief Executive Officer, with the vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology.

MedPlus Health Services Limited Promoter(s)

Gangadi Madhukar Reddy, Lone Furrow Investments Private Limited, Agilemed Investments Private Limited are the company's promoters of MedPlus Health Services Limited.

MedPlus Health Services Limited IPO Issue Objectives

Funding working capital requirements of their Material Subsidiary, Optival
General corporate purposes.

MedPlus Health Services Limited IPO - Anchor Investors

Medplus Health Services mobilises Rs 418 crore from anchor investors ahead of IPO

Marquee investors who showed interest in the company through the anchor book were Abu Dhabi Investment Authority, Blackrock Global Funds, Nomura, Fidelity Investment Trust, Goldman Sachs, Morgan Stanley, Wasatch International Opportunities Fund, Carmignac Portfolio, and CI Asian Tiger Fund.

Domestic investors including HDFC Trustee, Aditya Birla Sun Life, SBI Mutual Fund, Nippon Life, Kotak Mutual Fund, Motilal Oswal Mutual Fund, HDFC Life Insurance, ICICI Prudential Life Insurance, SBI Life Insurance, and Edelweiss also invested in the company

Contact Information

Frequently Asked Questions

Click any question to reveal the answer

MedPlus Health Services Limited IPO is a book-built IPO worth ₹1,397.81 Cr. The price band is ₹780–₹796 per share. The IPO opens on Dec 13, 2021 and closes on Dec 15, 2021. It will be listed on BSE and NSE. KFin Technologies Private Limited is the registrar.

The price band of MedPlus Health Services Limited IPO is ₹780 to ₹796 per share.

The lot size of MedPlus Health Services Limited IPO is 18 shares.

The minimum investment for MedPlus Health Services Limited IPO is approximately ₹14,328 based on the upper price band .

MedPlus Health Services Limited IPO opens on Dec 13, 2021 and closes on Dec 15, 2021.

The allotment date of MedPlus Health Services Limited IPO is Dec 20, 2021.

MedPlus Health Services Limited IPO is expected to be listed on Dec 23, 2021, on BSE and NSE .

MedPlus Health Services Limited IPO listed on Dec 23, 2021. It was issued at ₹1040.00(NSE) and is currently around ₹891.55 as on 14-May-2026 3:30 PM, which is approximately 12.0% versus issue price. The 52-week high is ₹1,045.30.

Based on listing and post-listing performance, MedPlus Health Services Limited IPO delivered around 12.0% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.

To buy MedPlus Health Services Limited IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.

MedPlus Health Services Limited IPO valuation snapshot: P/E 141.91, EPS ₹5.61/-, P/B N/A, RoNW 8.74%, and market cap N/A.

To apply for MedPlus Health Services Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.

You can check the live subscription status of MedPlus Health Services Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.

Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.

If you pre-apply for MedPlus Health Services Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.

You can check MedPlus Health Services Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the MedPlus Health Services Limited IPO allotment status on IPO Ji for quick and easy access.